In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

Recognizing the early signs of cognitive decline is essential for timely intervention, whether for yourself or a loved one.

Researchers from the International Working Group recommend categorizing biomarker-positive, cognitively normal individuals as ...

Director of the Alzheimer’s Association, Kristen Dickins said the Walk to End Alzheimer’s is something they do annually to ...

Alzheimer’s disease may cause cognitive complications like severe memory loss, mental health complications like depression, and physical complications like reduced mobility. Alzheimer’s ...

Data of Blarcamesine confirm upstream SIGMAR1 activationPresented as Late Breaking Oral Communications at Clinical Trials on Alzheimer’s Disease ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

AbbVie (ABBV) announced Monday that it is buying Aliada Therapeutics for $1.4 billion. The deal includes Aliada’s lead drug ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

Cassava Sciences ( (SAVA) ) has released its Q3 earnings. Here is a breakdown of the information Cassava Sciences presented to its investors.

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...